Yang Sheng, a member of the party group and deputy director of the State Drug Administration, led a delegation to Seoul, South Korea from November 2 to 5, 2026 to attend the International Drug Supervisory Authority Alliance summit and plenary session. The conference discussed topics such as the application of artificial intelligence in drug regulation, new methodologies and next-generation regulatory frameworks, and patient-centered drug development and regulation. The Chinese delegation delivered conference reports and discussion statements on these topics. During the meeting, the delegation held working talks with delegations from drug regulatory agencies such as the European Union, Singapore, Poland, South Korea and WHO representatives to have an in-depth exchange of views on topics such as deepening mutual trust and cooperation in drug regulation. Yang Sheng also had working exchanges with key heads of drug regulatory agencies such as the United Kingdom, Canada, Denmark, Portugal, Brazil, Egypt, and South Africa to further expand and deepen bilateral cooperation.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.